Sickle Cell Disease Treatment Market by Treatment Type (Pharmacotherapy, Bone Marrow Transplant, and Blood Transfusion), by End User (Hospitals, and Specialty Clinics), - Global Outlook & Forecast 2022-2030

  • Report Code : gpr833743
  • Pages : 180
  • Published On : Sep 2022
  • Industry : Healthcare and Pharmaceuticals
  • Format :

Choose License Type

Single User License: US$ 4,750
Multi User License: US$ 5,680
Corporate User License: US$ 7,750
The Sickle Cell Disease Treatment Market is predicted to reach US$ by 2030 from US$ 2.3 billion in 2021, and to grow at a CAGR of 15.3% between the forecast period 2022 to 2030.

The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.

Major segmentation covered in this report is as follows:

By Treatment Type (Pharmacotherapy, Bone Marrow Transplant, and Blood Transfusion), by End User (Hospitals, and Specialty Clinics)

By Region

North America, Europe, Asia Pacific, and the Rest of the World

Major market players covered in this study are

AstraZeneca Plc., Pfizer Inc., Bristol-Myers Squibb Company, Emmaus Life Sciences, Inc., Arena Pharmaceuticals, Inc., Bluebird Bio, Global Blood Therapeutics Inc., Sangamo Therapeutics, Inc., Eli Lilly and Company, and Alnylam Pharmaceuticals, Inc. among others

1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Sickle Cell Disease Treatment - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Sickle Cell Disease Treatment - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Sickle Cell Disease Treatment - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Sickle Cell Disease Treatment - ANALYSIS & FORECAST, BY REGION
North America Sickle Cell Disease Treatment
1. North America Sickle Cell Disease Treatment , by Country
1. US
2. Canada
1. North America Sickle Cell Disease Treatment , by Product
2. North America Sickle Cell Disease Treatment , by Type
3. North America Sickle Cell Disease Treatment , by Gender
4. North America Sickle Cell Disease Treatment , by Sales Channel
3. Europe Sickle Cell Disease Treatment
1. Europe Sickle Cell Disease Treatment , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Sickle Cell Disease Treatment , by Product
3. Europe Sickle Cell Disease Treatment , by Type
4. Europe Sickle Cell Disease Treatment , by Gender
5. Europe Sickle Cell Disease Treatment , by Sales Channel
4. Asia Pacific Sickle Cell Disease Treatment
1. Asia Pacific Sickle Cell Disease Treatment , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Sickle Cell Disease Treatment , by product
3. Asia Pacific Sickle Cell Disease Treatment , by Type
4. Asia Pacific Sickle Cell Disease Treatment , by Gender
5. Asia Pacific Sickle Cell Disease Treatment , by Sales Channel
5. Rest of the World Sickle Cell Disease Treatment
1. Rest of the World Sickle Cell Disease Treatment , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Sickle Cell Disease Treatment , by Product
3. Rest of the World Sickle Cell Disease Treatment , by Type
4. Rest of the World Sickle Cell Disease Treatment , by Gender
5. Rest of the World Sickle Cell Disease Treatment , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 83

CHO Cell Line Construction Service Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The CHO Cell Line Construction Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...

Cell Line Construction Service Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Cell Line Construction Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...

Cell Bank Creation Service Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Cell Bank Creation Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...

Cell Therapy Platform Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Cell Therapy Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers...

Cell and Gene Therapy Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Cell and Gene Therapy Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...

Cell Therapy Biomanufacturing Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Cell Therapy Biomanufacturing Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...

Treatment Management System Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Treatment Management System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...

Cell to Chassis Technology Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Cell to Chassis Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...

Hospital Treatment Fee Evaluation Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hospital Treatment Fee Evaluation Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...

Chronic Kidney Disease Management Technology Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Chronic Kidney Disease Management Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive l...